114 related articles for article (PubMed ID: 37878765)
41. Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma.
Hoppe BS; Hill-Kayser CE; Tseng YD; Flampouri S; Elmongy HM; Cahlon O; Mendenhall NP; Maity A; McGee LA; Plastaras JP
Ann Oncol; 2017 Sep; 28(9):2179-2184. PubMed ID: 28911093
[TBL] [Abstract][Full Text] [Related]
42. Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study.
Maggen C; Dierickx D; Lugtenburg P; Laenen A; Cardonick E; Shmakov RG; Bellido M; Cabrera-Garcia A; Gziri MM; Halaska MJ; Ottevanger PB; Van Calsteren K; O'Laughlin A; Polushkina E; Van Dam L; Avivi I; Vandenberghe P; Woei-A-Jin FJSH; Amant F;
Lancet Haematol; 2019 Nov; 6(11):e551-e561. PubMed ID: 31564649
[TBL] [Abstract][Full Text] [Related]
43. Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group.
Keller FG; Castellino SM; Chen L; Pei Q; Voss SD; McCarten KM; Senn SL; Buxton AB; Bush R; Constine LS; Schwartz CL
Cancer; 2018 Aug; 124(15):3210-3219. PubMed ID: 29738613
[TBL] [Abstract][Full Text] [Related]
44. Chemotherapy with a Pegylated Liposomal Doxorubicin-Containing Regimen in Newly Diagnosed Hodgkin Lymphoma Patients.
Liu W; Yang M; Ping L; Xie Y; Wang X; Zhu J; Song Y
Cardiovasc Toxicol; 2021 Jan; 21(1):12-16. PubMed ID: 32683546
[TBL] [Abstract][Full Text] [Related]
45. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?
De Sanctis V; Bolzan C; D'Arienzo M; Bracci S; Fanelli A; Cox MC; Valeriani M; Osti MF; Minniti G; Chiacchiararelli L; Enrici RM
Radiat Oncol; 2012 Aug; 7():129. PubMed ID: 22857015
[TBL] [Abstract][Full Text] [Related]
46. Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome.
Savage KJ; Skinnider B; Al-Mansour M; Sehn LH; Gascoyne RD; Connors JM
Blood; 2011 Oct; 118(17):4585-90. PubMed ID: 21873543
[TBL] [Abstract][Full Text] [Related]
47. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.
Pinnix CC; Smith GL; Milgrom S; Osborne EM; Reddy JP; Akhtari M; Reed V; Arzu I; Allen PK; Wogan CF; Fanale MA; Oki Y; Turturro F; Romaguera J; Fayad L; Fowler N; Westin J; Nastoupil L; Hagemeister FB; Rodriguez MA; Ahmed S; Nieto Y; Dabaja B
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):175-82. PubMed ID: 25863764
[TBL] [Abstract][Full Text] [Related]
48. Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group.
Schwartz CL; Chen L; McCarten K; Wolden S; Constine LS; Hutchison RE; de Alarcon PA; Keller FG; Kelly KM; Trippet TA; Voss SD; Friedman DL
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27786406
[TBL] [Abstract][Full Text] [Related]
49. MR imaging to detect chest wall and pleural involvement in patients with lymphoma: effect on radiation therapy planning.
Carlsen SE; Bergin CJ; Hoppe RT
AJR Am J Roentgenol; 1993 Jun; 160(6):1191-5. PubMed ID: 8498212
[TBL] [Abstract][Full Text] [Related]
50. Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma.
Paumier A; Ghalibafian M; Beaudre A; Ferreira I; Pichenot C; Messai T; Lessard NA; Lefkopoulos D; Girinsky T
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):199-205. PubMed ID: 21481723
[TBL] [Abstract][Full Text] [Related]
51. Protontherapy versus best photon for mediastinal Hodgkin lymphoma: Dosimetry comparison and treatment using ILROG guidelines.
Abbassi LM; Goudjil F; Arsène-Henry A; Dendale R; Kirova YM
Cancer Radiother; 2019 Dec; 23(8):922-925. PubMed ID: 31257097
[TBL] [Abstract][Full Text] [Related]
52. Can diffusion-weighted whole-body MRI replace contrast-enhanced CT for initial staging of Hodgkin lymphoma in children and adolescents?
Regacini R; Puchnick A; Luisi FAV; Lederman HM
Pediatr Radiol; 2018 May; 48(5):638-647. PubMed ID: 29362839
[TBL] [Abstract][Full Text] [Related]
53. Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma.
Song MK; Chung JS; Lee JJ; Jeong SY; Lee SM; Hong JS; Chong A; Moon JH; Kim JH; Lee SM; Kim SJ; Shin HJ
Cancer Sci; 2013 Dec; 104(12):1656-61. PubMed ID: 24033666
[TBL] [Abstract][Full Text] [Related]
54. High dose chemotherapy and autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: Emerging questions, newer agents, and changing paradigm.
Akhtar S
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):272-276. PubMed ID: 28641095
[TBL] [Abstract][Full Text] [Related]
55. PECAM is an effective and safe anthracycline-containing third-line regimen for patients with relapsed or refractory non-Hodgkin lymphoma.
Nakamura F; Arai H; Tokita K; Furuichi S; Sugita-Nagasawa F; Takahashi W; Handa T; Iso H; Tadokoro J; Tsurumi S; Nakamura Y; Nakamura Y; Sasaki K; Seo S; Ichikawa M; Mitani K
Leuk Lymphoma; 2021 Jan; 62(1):239-242. PubMed ID: 32914680
[No Abstract] [Full Text] [Related]
56. Radiation therapy for early stage unfavorable Hodgkin lymphoma: is dose reduction feasible?
Laskar S; Kumar DP; Khanna N; Menon H; Sengar M; Arora B; Gujral S; Shet T; Sridhar E; Rangarajan V; Muckaden MA; Nair R; Banavali S
Leuk Lymphoma; 2014 Oct; 55(10):2356-61. PubMed ID: 24354681
[TBL] [Abstract][Full Text] [Related]
57. The role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma.
Lawal IO; Nyakale NE; Harry LM; Modiselle MR; Ankrah AO; Msomi AP; Mokgoro NP; Boshomane TG; de Wiele CV; Sathekge MM
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2025-2033. PubMed ID: 28660348
[TBL] [Abstract][Full Text] [Related]
58. Asymptomatic bulky Hodgkin lymphoma over 8 years with elevated alpha fetoprotein.
Au WY; Wong SH; Suen WS; Ma ES; Chui WH
Leuk Lymphoma; 2014 Jan; 55(1):207-8. PubMed ID: 23597140
[No Abstract] [Full Text] [Related]
59. Classic Hodgkin Lymphoma: A Nonclassic Presentation.
Mattes M; Steele A; Chung J; Alvarez E
J Pediatr Hematol Oncol; 2021 Apr; 43(3):114-115. PubMed ID: 32433447
[TBL] [Abstract][Full Text] [Related]
60. Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial.
Georgi TW; Kurch L; Hasenclever D; Warbey VS; Pike L; Radford J; Sabri O; Kluge R; Barrington SF
PLoS One; 2020; 15(4):e0231027. PubMed ID: 32240248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
